Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thorsten E. Fisher is active.

Publication


Featured researches published by Thorsten E. Fisher.


Bioorganic & Medicinal Chemistry | 1994

Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages.

John S. Wai; Dona L. Bamberger; Thorsten E. Fisher; Samuel L. Graham; Smith Rl; Jackson B. Gibbs; Scott D. Mosser; Allen Oliff; David L. Pompliano; Elaine Rands; Nancy E. Kohl

Replacement of the central amino methylene linkage of C[psi CH2NH]A[psi CH2NH]AX tetrapeptide inhibitors with carbon tethers led to compounds with potency in the nanomolar range. Some of the more potent olefinic compounds inhibit Ras processing in intact v-ras transformed NIH 3T3 cells with IC50 values in the 0.1 to 1 microM range, and inhibit selectively the anchorage-independent growth of H-ras transformed Rat1 cells at 10 microM.


Tetrahedron Letters | 1995

An efficient synthesis of γ-alkylated E-olefin dipeptide isosteres

John S. Wai; Thorsten E. Fisher; Mark W. Embrey

Abstract An efficient synthetic sequence was developed for the preparation of γ-alkylated E-olefin isosteres of dipeptides.


Bioorganic & Medicinal Chemistry Letters | 2000

Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors.

Melissa S. Egbertson; Bohumil Bednar; Ben C. Askew; Rodney A. Bednar; Karen M. Brashear; Michael J. Breslin; Mark E. Duggan; Thorsten E. Fisher; Wasyl Halczenko; John H. Hutchinson; Nathan C. Ihle; John D. Prugh; John S. Wai; Robert J. Gould; George D. Hartman

Compound affinity for activated and resting GPIIb/IIIa receptors may differ, and comparison of those differences determines selectivity. Structural features that influence selectivity are discussed.


Synthetic Communications | 1996

Synthesis of 3-Alkyl-6-bromo-4,5-E-hexenoate

Mark W. Embrey; Thorsten E. Fisher; John S. Wai

Abstract Two complementary routes for the preparation of 3-alkyl-6-bromo-4,5-E-hexenoate are reported.


Proceedings of the National Academy of Sciences of the United States of America | 2004

A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase

Daria J. Hazuda; Neville J. Anthony; Robert P. Gomez; Samson M. Jolly; John S. Wai; Linghang Zhuang; Thorsten E. Fisher; Mark W. Embrey; James P. Guare; Melissa S. Egbertson; Joseph P. Vacca; Joel R. Huff; Peter J. Felock; Marc Witmer; Kara A. Stillmock; Robert Danovich; Jay A. Grobler; Michael D. Miller; Amy S. Espeseth; Lixia Jin; I-Wu Chen; Jiunn H. Lin; Kelem Kassahun; Joan D. Ellis; Bradley K. Wong; Wei Xu; Paul G. Pearson; William A. Schleif; Riccardo Cortese; Emilio A. Emini


Journal of Medicinal Chemistry | 2003

Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells

Linghang Zhuang; John S. Wai; Mark W. Embrey; Thorsten E. Fisher; Melissa S. Egbertson; Linda S. Payne; James P. Guare; Joseph P. Vacca; Daria J. Hazuda; Peter J. Felock; Abigail Wolfe; Kara A. Stillmock; Marc Witmer; Gregory Moyer; William A. Schleif; Lori J. Gabryelski; Yvonne M. Leonard; Joseph J. Lynch; Stuart R. Michelson; Steven D. Young


Journal of Medicinal Chemistry | 2000

4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells.

John S. Wai; Melissa S. Egbertson; Linda S. Payne; Thorsten E. Fisher; Mark W. Embrey; Lekhanh O. Tran; Jeffrey Y. Melamed; H. Marie Langford; James P. Guare; Linghang Zhuang; Vanessa E. Grey; Joseph P. Vacca; M. Katharine Holloway; Adel M. Naylor-Olsen; Daria J. Hazuda; Peter J. Felock; Abigail Wolfe; Kara A. Stillmock; William A. Schleif; and Lori J. Gabryelski; Steven D. Young


Journal of Medicinal Chemistry | 1991

2-pyridinone derivatives : a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors

Walfred S. Saari; Hoffman Jm; John S. Wai; Thorsten E. Fisher; Rooney Cs; Smith Am; Thomas Cm; Mark E. Goldman; Julie A. O'Brien; Nunberg Jh


Journal of Medicinal Chemistry | 1992

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2: Analogues of 3-aminopyridin-2(1H=-one

Walfred S. Saari; John S. Wai; Thorsten E. Fisher; Thomas Cm; Hoffman Jm; Rooney Cs; Smith Am; James H. Jones; Dona L. Bamberger


Journal of Medicinal Chemistry | 1993

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogues.

Hoffman Jm; Smith Am; Rooney Cs; Thorsten E. Fisher; John S. Wai; Thomas Cm; Dona L. Bamberger; Barnes Jl; Theresa M. Williams; James H. Jones

Collaboration


Dive into the Thorsten E. Fisher's collaboration.

Top Co-Authors

Avatar

John S. Wai

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

Mark W. Embrey

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

Linghang Zhuang

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

Steven D. Young

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

James P. Guare

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

H. Marie Langford

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

Jeffrey Y. Melamed

United States Military Academy

View shared research outputs
Researchain Logo
Decentralizing Knowledge